Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Anticonvulsant and antiepileptogenic effects of system x c - inactivation in chronic epilepsy models.

Leclercq K, Liefferinge JV, Albertini G, Neveux M, Dardenne S, Mairet-Coello G, Vandenplas C, Deprez T, Chong SA, Foerch P, Bentea E, Sato H, Maher P, Massie A, Smolders I, Kaminski RM.

Epilepsia. 2019 Jul;60(7):1412-1423. doi: 10.1111/epi.16055. Epub 2019 Jun 9.

PMID:
31179549
2.

Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.

Albert M, Mairet-Coello G, Danis C, Lieger S, Caillierez R, Carrier S, Skrobala E, Landrieu I, Michel A, Schmitt M, Citron M, Downey P, Courade JP, Buée L, Colin M.

Brain. 2019 Jun 1;142(6):1736-1750. doi: 10.1093/brain/awz100.

3.

Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau.

Courade JP, Angers R, Mairet-Coello G, Pacico N, Tyson K, Lightwood D, Munro R, McMillan D, Griffin R, Baker T, Starkie D, Nan R, Westwood M, Mushikiwabo ML, Jung S, Odede G, Sweeney B, Popplewell A, Burgess G, Downey P, Citron M.

Acta Neuropathol. 2018 Nov;136(5):729-745. doi: 10.1007/s00401-018-1911-2. Epub 2018 Sep 20.

4.

A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target.

Srivastava PK, van Eyll J, Godard P, Mazzuferi M, Delahaye-Duriez A, Van Steenwinckel J, Gressens P, Danis B, Vandenplas C, Foerch P, Leclercq K, Mairet-Coello G, Cardenas A, Vanclef F, Laaniste L, Niespodziany I, Keaney J, Gasser J, Gillet G, Shkura K, Chong SA, Behmoaras J, Kadiu I, Petretto E, Kaminski RM, Johnson MR.

Nat Commun. 2018 Sep 3;9(1):3561. doi: 10.1038/s41467-018-06008-4.

5.

The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.

Vermeiren C, Motte P, Viot D, Mairet-Coello G, Courade JP, Citron M, Mercier J, Hannestad J, Gillard M.

Mov Disord. 2018 Feb;33(2):273-281. doi: 10.1002/mds.27271. Epub 2017 Dec 26.

PMID:
29278274
6.

Involvement of 'stress-response' kinase pathways in Alzheimer's disease progression.

Mairet-Coello G, Polleux F.

Curr Opin Neurobiol. 2014 Aug;27:110-7. doi: 10.1016/j.conb.2014.03.011. Epub 2014 Apr 5. Review.

7.

The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation.

Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A, Polleux F.

Neuron. 2013 Apr 10;78(1):94-108. doi: 10.1016/j.neuron.2013.02.003.

8.

p57(KIP2) regulates radial glia and intermediate precursor cell cycle dynamics and lower layer neurogenesis in developing cerebral cortex.

Mairet-Coello G, Tury A, Van Buskirk E, Robinson K, Genestine M, DiCicco-Bloom E.

Development. 2012 Feb;139(3):475-87. doi: 10.1242/dev.067314.

9.

The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.

Tury A, Mairet-Coello G, DiCicco-Bloom E.

Dev Neurobiol. 2012 Jun;72(6):821-42. doi: 10.1002/dneu.20999. Review.

10.

The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.

Tury A, Mairet-Coello G, DiCicco-Bloom E.

Cereb Cortex. 2011 Aug;21(8):1840-56. doi: 10.1093/cercor/bhq254. Epub 2011 Jan 18.

12.

Patterns of p57Kip2 expression in embryonic rat brain suggest roles in progenitor cell cycle exit and neuronal differentiation.

Ye W, Mairet-Coello G, Pasoreck E, Dicicco-Bloom E.

Dev Neurobiol. 2009 Jan;69(1):1-21. doi: 10.1002/dneu.20680.

13.

DNAse I pre-treatment markedly enhances detection of nuclear cyclin-dependent kinase inhibitor p57Kip2 and BrdU double immunostaining in embryonic rat brain.

Ye W, Mairet-Coello G, DiCicco-Bloom E.

Histochem Cell Biol. 2007 Feb;127(2):195-203. Epub 2006 Oct 6.

PMID:
17024454
14.

Identification and expression of a new splicing variant of FAD-sulfhydryl oxidase in adult rat brain.

Radom J, Colin D, Thiebault F, Dognin-Bergeret M, Mairet-Coello G, Esnard-Feve A, Fellmann D, Jouvenot M.

Biochim Biophys Acta. 2006 May;1759(5):225-33. Epub 2006 May 9.

PMID:
16806532
15.

Cell-specific localization of the sulphydryl oxidase QSOX in rat peripheral tissues.

Tury A, Mairet-Coello G, Esnard-Fève A, Benayoun B, Risold PY, Griffond B, Fellmann D.

Cell Tissue Res. 2006 Jan;323(1):91-103. Epub 2005 Sep 14.

PMID:
16160860
16.

Expression of the sulfhydryl oxidase ALR (Augmenter of Liver Regeneration) in adult rat brain.

Tury A, Mairet-Coello G, Lisowsky T, Griffond B, Fellmann D.

Brain Res. 2005 Jun 28;1048(1-2):87-97.

PMID:
15916753
17.

Ontogenesis of the sulfhydryl oxidase QSOX expression in rat brain.

Mairet-Coello G, Tury A, Fellmann D, Risold PY, Griffond B.

J Comp Neurol. 2005 Apr 18;484(4):403-17.

PMID:
15770657
18.

QSOX sulfhydryl oxidase in rat adenohypophysis: localization and regulation by estrogens.

Tury A, Mairet-Coello G, Poncet F, Jacquemard C, Risold PY, Fellmann D, Griffond B.

J Endocrinol. 2004 Nov;183(2):353-63.

PMID:
15531723
19.

FAD-linked sulfhydryl oxidase QSOX: topographic, cellular, and subcellular immunolocalization in adult rat central nervous system.

Mairet-Coello G, Tury A, Esnard-Feve A, Fellmann D, Risold PY, Griffond B.

J Comp Neurol. 2004 May 31;473(3):334-63.

PMID:
15116395
20.

Expression of SOx-2, a member of the FAD-dependent sulfhydryl oxidase/quiescin Q6 gene family, in rat brain.

Mairet-Coello G, Tury A, Fellmann D, Jouvenot M, Griffond B.

Neuroreport. 2002 Nov 15;13(16):2049-51.

PMID:
12438924
21.

Orexin/hypocretin neurons: chemical phenotype and possible interactions with melanin-concentrating hormone neurons.

Bayer L, Mairet-Coello G, Risold PY, Griffond B.

Regul Pept. 2002 Mar 15;104(1-3):33-9.

PMID:
11830274

Supplemental Content

Loading ...
Support Center